R&D for 3rd partiesiMedVi2020-03-26T16:46:02+01:00
R&D for 3rd parties
Our technology is transversal, which allows us to apply it to the different biomedical fields
i+Med has a broad experience in customized developments for clients of different biomedical sectors. Many of them have reached the certification and marketing stages. Several examples of the developed products are shown herein:
Management of acute post-surgical pain
Intradermal fillers, monophasic and biphasic, with controlled release of vitamin complexes.
Coatings for implants, vascular inserts, stents, catheters, etc.
Viscoelastics: replacement of the vitreous and aqueous humour in cataracts surgery.
Development of eye drops, ophthalmic liquids, gels, to treat several eye conditions, infections and wounds.
Non viral vectors: vehiculization of therapeutic molecules, toxic or unstable molecules. Increase biodisponibility and efficacy, decreasing the toxicity and the required dose.
Development of formulations to enable the access of the therapy to locations of difficult access.
ORAL / NASAL
Mucus penetration of drugs.
UROLOGY / GYNAECOLOGY
Controlled release of drugs
SPORTS MEDICINE LINE
Gels, creams, and other products for topical application, with therapeutic properties that enable recovery after physical effort and with antimicrobial properties.
Oral mucoadhesive product.
Utilizamos cookies propias y de terceros para mejorar nuestros servicios. Si continuas navegando, consideramos que aceptas su uso. Puedes obtener más información aquí.AceptarRechazar
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.